Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Denmark
Pharma
Fujifilm Diosynth CEO marks 2025 as era of expansion execution
By late summer, Fujifilm Diosynth's CEO expects “basically half” of the company’s $8 billion in manufacturing investments to be “in operation."
Fraiser Kansteiner
Jan 24, 2025 12:12pm
Novo Nordisk to build $1.2B rare disease drug factory in Denmark
Dec 16, 2024 10:26am
Novo unveils plans for $400M quality control hub in Denmark
Dec 4, 2024 2:53pm
FDA scrutinizes Novo on production issues at semaglutide plant
Oct 31, 2024 9:33am
Leo Pharma to chop or relocate 250 roles under ongoing revamp
Oct 9, 2024 4:28pm
Novo Nordisk plans new $220M raw ingredients plant
Aug 16, 2024 11:20am
 resize.jpg?VersionId=xqZRoAgddGv5oDcof4BTLR_AkI0X48c_)
